Maintenance fees coming due
7 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Jan 30, 2027. Unpaid by Jul 30, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,363,259 | Fulvestrant Formulations In force Fee due Jan 30, 2027 Lapses if unpaid Jul 30, 2027 · High confidence | Eagle Pharmaceuticals, Inc. | In force | Jan 30, 2027 | Jul 30, 2027 | High confidence | |
| US 9,144,568 | Formulations of Bendamustine In force Fee due Mar 29, 2027 Lapses if unpaid Sep 29, 2027 · High confidence | Eagle Pharmaceuticals, Inc. | In force | Mar 29, 2027 | Sep 29, 2027 | High confidence | |
| US 11,793,813 | Pemetrexed Formulations In force Fee due Apr 24, 2027 Lapses if unpaid Oct 25, 2027 · Low confidence | Eagle Pharmaceuticals, Inc. | In force | Apr 24, 2027 | Oct 25, 2027 | Low confidence | |
| US 9,180,088 | Fulvestrant formulations In force Fee due May 10, 2027 Lapses if unpaid Nov 10, 2027 · High confidence | Eagle Pharmaceuticals, Inc. | In force | May 10, 2027 | Nov 10, 2027 | High confidence | |
| US 11,844,783 | Formulations of Bendamustine In force Fee due Jun 19, 2027 Lapses if unpaid Dec 20, 2027 · Medium confidence | Eagle Pharmaceuticals, Inc. | In force | Jun 19, 2027 | Dec 20, 2027 | Medium confidence | |
| US 11,872,214 | Formulations of Bendamustine In force Fee due Jul 16, 2027 Lapses if unpaid Jan 18, 2028 · Medium confidence | Eagle Pharmaceuticals, Inc. | In force | Jul 16, 2027 | Jan 18, 2028 | Medium confidence | |
| US 9,265,831 | Formulations of Bendamustine In force Fee due Aug 23, 2027 Lapses if unpaid Feb 23, 2028 · High confidence | Eagle Pharmaceuticals, Inc. | In force | Aug 23, 2027 | Feb 23, 2028 | High confidence |
7 of 7 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.